Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bartlmanon Jul 24, 2018 8:06pm
145 Views
Post# 28362218

RE:RE:FDA FAST TRACKS CANCER TREATMENT

RE:RE:FDA FAST TRACKS CANCER TREATMENTI'm not sure a lot of you folks know this but oncolytic viruses have been around for a long time and many companies have, and are, persuing them with various degrees of success. 20 years or so ago I invested in ONC (Oncolytics TSX.V - ONCY stateside) which has developed the so-called reovirus, a common gut virus that had rather mild side effects when administered other than their dastardly effect on cancer cells. They are still an active concern based in Calgary. Not sure what indications they're working on at the moment - lost interest years ago but some of you may wish to check it out. They are an example of a company that lost focus and had so many things going on that they ran out of money. Instead of following one indication to conclusion, they started trialing in multiple indications and simply were not able to bring any one clinical trial to fruition. I believe they may have been granted orphan drug status on something recently.
Bullboard Posts